Incident users of tyrosine kinase inhibitors in patients with chronic myeloid leukemia: Analysis of anticancer treatment trajectories-A French population-based study using the French national health data system.

Authors :: Vabre C
Zelmat Y
Gauthier M
Pajiep M
Conte C
Lapeyre-Mestre M
Dray-Spira R
Zureik M
Despas F
Source :: American journal of hematology [Am J Hematol] 2022 Aug; Vol. 97 (8), pp. E307-E309. Date of Electronic Publication: 2022 Jun 07.
Publication Year :: 2022

Subjects :: Fusion Proteins, bcr-abl genetics
Humans
Protein Kinase Inhibitors therapeutic use
Leukemia, Myelogenous, Chronic, BCR-ABL Positive drug therapy

Full Text Access

Tools